相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control
Asier Gonzalez et al.
CELL METABOLISM (2020)
Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility
Chongyang Li et al.
NATURE COMMUNICATIONS (2020)
Absence of MHC class II on cDC1 dendritic cells triggers fatal autoimmunity to a cross-presented self-antigen
Christian Wohn et al.
SCIENCE IMMUNOLOGY (2020)
Allogeneic dendritic cells induce potent antitumor immunity by activating KLRG1+CD8 T cells
Chao Wang et al.
SCIENTIFIC REPORTS (2019)
Regulation of Antigen Export to the Cytosol During Cross-Presentation
Marine Gros et al.
FRONTIERS IN IMMUNOLOGY (2019)
Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responses
Grammatiki Fotaki et al.
ONCOIMMUNOLOGY (2018)
Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models
Grammatiki Fotaki et al.
ONCOIMMUNOLOGY (2018)
Nuclear Receptor Nur77 Limits the Macrophage Inflammatory Response through Transcriptional Reprogramming of Mitochondrial Metabolism
Duco Steven Koenis et al.
CELL REPORTS (2018)
Genome-wide RNAi Screen for Fat Regulatory Genes in C-elegans Identifies a Proteostasis-AMPK Axis Critical for Starvation Survival
Christopher M. Webster et al.
CELL REPORTS (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity
Michael Rasmussen et al.
JOURNAL OF IMMUNOLOGY (2016)
Antitumor dendritic cell-based vaccines: lessons from 20 years of clinical trials and future perspectives
Joao Constantino et al.
TRANSLATIONAL RESEARCH (2016)
Lipid peroxidation causes endosomal antigen release for cross-presentation
Ilse Dingjan et al.
SCIENTIFIC REPORTS (2016)
The Translocon Protein Sec61 Mediates Antigen Transport from Endosomes in the Cytosol for Cross-Presentation to CD8+ T Cells
Matthias Zehner et al.
IMMUNITY (2015)
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
Nikolaos Patsoukis et al.
NATURE COMMUNICATIONS (2015)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity (vol 26, pg 638, 2014)
Miranda L. Broz et al.
CANCER CELL (2014)
Immunoproteasomes Shape the Transcriptome and Regulate the Function of Dendritic Cells
Danielle A. de Verteuil et al.
JOURNAL OF IMMUNOLOGY (2014)
Minireview: Hey U(PS): Metabolic and Proteolytic Homeostasis Linked via AMPK and the Ubiquitin Proteasome System
Sarah M. Ronnebaum et al.
MOLECULAR ENDOCRINOLOGY (2014)
Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy
Patty Sachamitrt et al.
FRONTIERS IN IMMUNOLOGY (2014)
The ATP Costs and Time Required to Degrade Ubiquitinated Proteins by the 26 S Proteasome
Andreas Peth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation
Lillian Cohn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells
Bithi Chatterjee et al.
BLOOD (2012)
Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity
Mikkel Harndahl et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141+ XCR1+ dendritic cells
K. M. Silk et al.
GENE THERAPY (2012)
Intracellular events regulating cross-presentation
Claudia S. Wagner et al.
FRONTIERS IN IMMUNOLOGY (2012)
Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation
Paul J. Tacken et al.
BLOOD (2011)
PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells
Katarzyna Karwacz et al.
EMBO MOLECULAR MEDICINE (2011)
Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells
Brian T. Edelson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Deletion of Immunoproteasome Subunits Imprints on the Transcriptome and Has a Broad Impact on Peptides Presented by Major Histocompatibility Complex I molecules
Danielle de Verteuil et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties
Moira Francois et al.
BLOOD (2009)
The Small GTPase Rac2 Controls Phagosomal Alkalinization and Antigen Crosspresentation Selectively in CD8+ Dendritic Cells
Ariel Savina et al.
IMMUNITY (2009)
Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy
Nicoletta Eliopoulos et al.
CANCER RESEARCH (2008)
A critical role of IFNγ in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1
Huiming Sheng et al.
CELL RESEARCH (2008)
Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity
Kai Hildner et al.
SCIENCE (2008)
Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes
Carolina Jancic et al.
NATURE CELL BIOLOGY (2007)
NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells
Ariel Savina et al.
CELL (2006)
Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-γ
Jennifer L. Chan et al.
BLOOD (2006)
Interferon-γ-stimulated marrow stromal cells:: a new type of nonhematopoietic antigen-presenting cell
J Stagg et al.
BLOOD (2006)
Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation
J Chapiro et al.
JOURNAL OF IMMUNOLOGY (2006)
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
RV Parry et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Dendritic cell dysfunction in cancer:: A mechanism for immunosuppression
A Pinzon-Charry et al.
IMMUNOLOGY AND CELL BIOLOGY (2005)
Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo
D Accapezzato et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
IFN-γ-induced immune adaptation of the proteasome system is an accelerated and transient response
S Heink et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Dendritic cell immunotherapy: mapping the way
CG Figdor et al.
NATURE MEDICINE (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization
LD Meirelles et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex
K Le Blanc et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2003)
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products
REM Toes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells
EM Hiltbold et al.
JOURNAL OF IMMUNOLOGY (2000)